Skip to main content
GWGovwatch
CongressBillsCommitteesPresidentMoneyPulseMisconductElectionsMap
Donate

Weekly accountability digest

One email a week with new votes, moving bills, and misconduct updates. No spam.

GW

Govwatch. Public data about Congress, in one place, in plain English.

Built with public data. Not affiliated with the U.S. government.

Explore

  • Officials
  • Legislation
  • Committees
  • Congress Pulse
  • Trending Topics
  • Bipartisan Leaderboard
  • Weekly Digest
  • Misconduct
  • Predictions

Learn

  • How Congress Works
  • How a Bill Becomes Law
  • Campaign Finance 101
  • Glossary

Tools

  • My Representatives
  • Compare Members
  • Bill Watchlist
  • Search
  • District Map
  • Follow the Money
  • Watch Live

Site

  • About
  • Contact
  • Corrections
  • Privacy Policy
  • Terms of Service

Data Sources

Congress.gov API v3
Bills, members, votes
GovInfo API
Floor speeches, reports, bill text
Federal Election Commission (FEC)
Campaign finance
VoteView (UCLA)
Ideology scores (DW-NOMINATE)
GovTrack.us
Misconduct data (CC0)
U.S. Census Bureau
District demographics
Support This Project

This site is free. Donations help cover hosting, API fees, and keeping the data fresh.

All data is sourced from official government APIs and public records. This site is for informational purposes only.

© 2026 Govwatch

HR2450Referred to Committee

Prescription Drug Transparency and Affordability Act

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-03-27
Introduced
3
Cosponsors
HR
ⓘ
Type

Sponsor

Kristen McDonald Rivet
Kristen McDonald Rivet
Democrat · MI · Representative
Votes with party: 91.7% (553 recorded votes)

Full profile: /officials/M001237

Source: Congress.gov · FEC

Cosponsors (3)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

  • Earl L. "Buddy" Carter (R-GA-1)Original· 2025-03-27
  • John James (R-MI-10)Original· 2025-03-27
  • Robert Menendez (D-NJ-8)Original· 2025-03-27

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

2025-03-27

Source: Congress.gov

Committee Activity

Currently in

  • House Committee on Education and WorkforceReferred To · 2025-03-27
  • House Committee on Ways and MeansReferred To · 2025-03-27
  • House Committee on Energy and CommerceReferred To · 2025-03-27

Previously

  • Education and Workforce CommitteeReferred To · 2025-03-27
  • Ways and Means CommitteeReferred To · 2025-03-27
  • Energy and Commerce CommitteeReferred To · 2025-03-27

Plain-English Summary

This bill would require pharmaceutical companies to disclose more information about how they set drug prices and would give the government more power to negotiate lower prices for medications, particularly for Medicare patients. The changes would likely affect both drug manufacturers and patients who struggle to afford prescription medications. The bill has been referred to multiple House committees for review and consideration.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Health
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.

  • HR7069Affordable Food and Energy Act of 2026
    Referred to Committee · 2026-05-20
  • HR8698Lower Prices at the Pump Act
    Referred to Committee · 2026-05-07
  • HR8305Working Parents Tax Relief Act of 2026
    Referred to Committee · 2026-04-15
  • HR8056Military Financial Literacy Act of 2026
    Referred to Committee · 2026-03-24